英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Methyl heptadecanoate |
十七烷酸甲酯 |
1731-92-6 |
詳細(xì)
|
Ditryptophenaline |
DITRYPTOPHENALINE |
64947-43-9 |
詳細(xì)
|
Etoxybamide |
Butanamide, 4-hydroxy-N-(2-hydroxyethyl)- |
66857-17-8 |
詳細(xì)
|
Hemiasterlin;NSC 695242;NSC-695242;Milnamide B;NSC695242;(-)-Hemiasterlin |
哈米特林 |
157207-90-4 |
詳細(xì)
|
NSC 341077;NSC341077;NSC-341077 |
甲氨蝶呤雜質(zhì) |
73610-81-8 |
詳細(xì)
|
Ammonium, ((p-diethylmethylammonio)phenethyl)diethylmethyl-, diiodide |
|
63977-59-3 |
詳細(xì)
|
Neogrifolin |
NEOGRIFOLIN |
23665-96-5 |
詳細(xì)
|
LS 34;LS34;LS-34 |
化合物 T32895 |
83726-79-8 |
詳細(xì)
|
Pyranojacareubin |
PYRANOJACAREUBIN |
78343-62-1 |
詳細(xì)
|
Solven;Jamylene;Danthron - DSS;DSS-danthron |
化合物 T34681 |
8059-64-1 |
詳細(xì)
|
Lopobutan |
化合物 T32874 |
6582-30-5 |
詳細(xì)
|
Phytic acid;inositol polyphosphate;Fytic Acid;myo-Inositol, hexakis(dihydrogen phosphate);Inositol hexaphosphate;inositol hexakisphosphate |
植酸 |
83-86-3 |
詳細(xì)
|
Jacareubin |
2H,6H-Pyrano(3,2-b)xanthen-6-one, 5,9,10-trihydroxy-2,2-dimethyl- |
3811-29-8 |
詳細(xì)
|
n-Decanohydroxamic acid;Decanohydroxamic acid;Caprinohydroxamic acid;N-Hydroxydecanamide |
Decanamide, N-hydroxy- |
2259-85-0 |
詳細(xì)
|
NSC127916;NSC 127916;NSC-127916 |
化合物 T33750 |
27150-04-5 |
詳細(xì)
|
T3Inh-1 |
化合物T3INH-1 |
50440-30-7 |
詳細(xì)
|
Cis-ACBD;cis-1-aminocyclobutane-1,3-dicarboxylic acid |
氨基二羧酸 |
73550-55-7 |
詳細(xì)
|
m-Dioxane, 5-methyl-4-phenyl-, cis- |
|
2033-27-4 |
詳細(xì)
|
Ganoderic acid C1 |
靈芝酸 C1 |
95311-97-0 |
詳細(xì)
|
Benzamide, N-(5-(p-aminophenoxy)pentyl)-N-methyl- |
|
102008-49-1 |
詳細(xì)
|
LY-228729 |
LY-228729 |
137641-36-2 |
詳細(xì)
|
Colchicine, deacetamido-5,6-didehydro-;Colchicine;deacetamido-6-dehydro- (7CI);Deacetamido-6-dehydrocolchicine |
|
14511-67-2 |
詳細(xì)
|
m-Anisidine, 4-((1-methylheptyl)oxy)-, hydrochloride |
|
15382-67-9 |
詳細(xì)
|
Ampelopsin A |
Benzo[6,7]cyclohepta[1,2,3-cd]benzofuran-4,6,8,10-tetrol,1,6,7,11b-tetrahydro-1,7-bis(4-hydroxyphenyl)-, (1S,6R,7S,11bS)- |
130608-11-6 |
詳細(xì)
|
AC 3092;AC-3092;AC3092 |
化合物 T29535 |
7558-14-7 |
詳細(xì)
|
HSP70-IN-1 |
1268273-90-0 |
1268273-90-0 |
詳細(xì)
|
Ellipticine hydrochloride;NSC 71795 (hydrochloride);Ellipticine HCl |
玫瑰樹堿鹽酸鹽 |
5081-48-1 |
詳細(xì)
|
Nystatin A3;Fungicidin;Nystatin |
制霉菌素 A3 |
62997-67-5 |
詳細(xì)
|
Amifostine trihydrate;WR2721;Amifostine;Ethyol trihydrate |
氨磷汀三水合物 |
112901-68-5 |
詳細(xì)
|
Bay 41-4109 racemate |
3-羥基-2-吡咯烷酮 |
298708-79-9 |
詳細(xì)
|
Fenaminstrobin;SYP1620;SYP-1620;SYP 1620 |
烯肟菌胺 |
366815-39-6 |
詳細(xì)
|
FIN56 |
FIN56 |
1083162-61-1 |
詳細(xì)
|
Vilaprisan;BAY1002670;BAY-10-02670;BAY-1002670;BAY 10-02670;BAY 1002670;BAY10-02670 |
Vistusertib |
1262108-14-4 |
詳細(xì)
|
Henagliflozin;SHR-3824;SHR 3824;SHR3824 |
化合物 T32058 |
1623804-44-3 |
詳細(xì)
|
Strontium Malonate;NBS101;NBS-101;NBS 101 |
化合物 T28870 |
63524-05-0 |
詳細(xì)
|
Melflufen;J 1;Melphalan flufenamide;J-1;J1;Prodrug J-1, Melflufen, Melphalan flufenamide |
Melphalan Flufenamide |
380449-51-4 |
詳細(xì)
|
Vps34-PIK-III;PIK-III;VPS34-IN2 |
PIK-III |
1383716-40-2 |
詳細(xì)
|
SBI-0640756;SBI-756;SBI 0640756;SBI0640756 |
CS-2838 |
1821280-29-8 |
詳細(xì)
|
OICR-9429;OICR9429;OICR 9429 |
OICR-9429 |
1801787-56-3 |
詳細(xì)
|
9-Oxooctadeca-10,12-dienoic acid;9-Oxo-10,12-octadecadienoic acid |
9-OXOOCTADECA-10,12-DIENOIC ACID |
54232-58-5 |
詳細(xì)
|
CXD101;CXD-101 |
CXD-101 |
934828-12-3 |
詳細(xì)
|
Neuropeptide Y (human);Human neuropeptide Y (29-64);Neuropeptide Y (29-64), amide, human |
神經(jīng)肽-Y (人, 鼠) |
90880-35-6 |
詳細(xì)
|
Hypidone hydrochloride;YL0919 |
CS-2407 |
1339058-04-6 |
詳細(xì)
|
NMS-P118 |
2-[1-(4,4-二氟環(huán)己基)-4-哌啶基]-6-氟-2,3-二氫-3-氧代-1H-異吲哚-4-甲酰胺 |
1262417-51-5 |
詳細(xì)
|
Dihydrokavain;7,8-Dihydrokawain;7,8-Dihydrokavain;Marindinin |
二氫醉椒素 |
587-63-3 |
詳細(xì)
|
IACS-010759;IACS-10759;IACS10759;IACS 10759 |
5-(5-甲基-1-(3-(4-(甲基磺?;?哌啶-1-基)芐基)-1H-1,2,4-三唑-3-基)-3-(4-(三氟甲氧基)苯基)-1,2,4-惡二唑 |
1570496-34-2 |
詳細(xì)
|
TAK-259 HCl;TAK-259;TAK259 |
化合物 T34774 |
1192347-42-4 |
詳細(xì)
|
APS-2-79 hydrochloride;APS-2-79;APS-2-79 HCl |
APS-2-79 鹽酸鹽 |
2002381-31-7 |
詳細(xì)
|
Thalidomide 4-fluoride;E3 ligase Ligand 4 |
2-(2,6-二氧代-哌啶-3-基)-4-氟基-異吲哚-1,3-二酮 |
835616-60-9 |
詳細(xì)
|
Parkeyl acetate |
帕克醇乙酸酯 |
55570-91-7 |
詳細(xì)
|
Amcasertib;BBI503 |
AMCASERTIB |
1129403-56-0 |
詳細(xì)
|
CFMTI |
2-CYCLOPROPYL-5-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYL-1H-1,2,3-TRIAZOL-4-YL]-2,3-DIHYDRO-1H-ISOINDOL-1-ONE |
864864-17-5 |
詳細(xì)
|
DL-Goitrin;Goitrin |
DL-甲狀腺腫素 |
13190-34-6 |
詳細(xì)
|
Cumene, m-ethyl- |
1-乙基-3-異丙基苯 |
4920-99-4 |
詳細(xì)
|
BI-9564;BI9564;BI 9564 |
化合物BI9564 |
1883429-22-8 |
詳細(xì)
|
SirReal2 |
乙酰胺,2-[(4,6-二甲基-2-嘧啶基)硫]-N-[5-(1-萘甲基)-2-噻唑]- |
709002-46-0 |
詳細(xì)
|
Piperolein A |
(E)-7-(benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one |
30505-92-1 |
詳細(xì)
|
GS-444217;GS 444217;GS444217 |
ASK1-IN-1 |
1262041-49-5 |
詳細(xì)
|
Phenazine methylsulfate;Phenazine methosulfate |
5-甲基吩嗪硫酸甲酯 |
299-11-6 |
詳細(xì)
|
PCC0208009;IDO-IN-2;DO-IN-2;IDO inhibitor 1 |
IDO-IN-2 |
1668565-74-9 |
詳細(xì)
|
Eupteleasaponin I |
EUPTELEASAPONIN?I |
290809-29-9 |
詳細(xì)
|
Nudicaucin B |
NUDICAUCIN B |
211557-36-7 |
詳細(xì)
|
MX69 |
MX69 |
1005264-47-0 |
詳細(xì)
|
CHM-081;CHM 081;CHM081 |
JWH 081-N-(cyclohexylmethyl) analog |
1373876-34-6 |
詳細(xì)
|
Tebanicline hydrochloride;Ebanicline hydrochloride;ABT-594 hydrochloride |
ABT594鹽酸鹽 |
203564-54-9 |
詳細(xì)
|
Y-29794 Tosylate;Y-29794;Y 29794 tosylate;Y29794;Y 29794;Y29794 tosylate |
Y-29794 tosylate |
143984-17-2 |
詳細(xì)
|
TC11;1H-Isoindole-1,3(2H)-dione, 5-amino-2-[2,6-bis(1-methylethyl)phenyl]-TC11;CLT-003 |
5-氨基-2-(2,6-二異丙基苯基)異吲哚啉-1,3-二酮 |
100823-03-8 |
詳細(xì)
|
V 2307;V-2307;V2307 |
化合物 T35007 |
101191-06-4 |
詳細(xì)
|
D-Arabinose |
D-阿拉伯糖 |
10323-20-3 |
詳細(xì)
|
EC330 |
LIF抑制劑(EC330) |
2016795-77-8 |
詳細(xì)
|
PF-CBP1 |
化合物PF-CBP1 |
1962928-21-7 |
詳細(xì)
|
Pinocembrin-7-O-β-D-glucopyranoside;Pinocembrin 7-O-beta-D-glucoside |
喬松素7-O-Β-D葡萄糖苷,喬松苷 |
75829-43-5 |
詳細(xì)
|
C29 |
TLR2-IN-C29 |
363600-92-4 |
詳細(xì)
|
JNJ-63533054;JNJ63533054;JNJ 63533054 |
3-氯-N-[2-氧代-2-[[(1S)-1-苯基乙基]氨基]乙基]苯甲酰胺 |
1802326-66-4 |
詳細(xì)
|
Acanthopanaxoside B |
番瀉苷C |
915792-03-9 |
詳細(xì)
|
17-Hydroxyisolathyrol |
17-羥基異千金二萜醇 |
93551-00-9 |
詳細(xì)
|
URB602 |
3-(環(huán)已氧羰基胺基)聯(lián)苯 |
565460-15-3 |
詳細(xì)
|
(E)-3PO;3PO |
3-(3-吡啶基)-1-(4-吡啶基)-2-丙烯-1-酮 |
13309-08-5 |
詳細(xì)
|
TTA-A2 |
2(4-環(huán)丙基苯基)-N[(1R)- 1 -[5 -(2,2,2-三氟乙氧基)吡啶-2-基]乙基]乙酰胺 |
953778-63-7 |
詳細(xì)
|
OSU-T315;OSU-T315 (1,5-regioisomer);ILK-IN-2 |
OSU-T315 |
2070015-22-2 |
詳細(xì)
|
5-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
泊馬度胺雜質(zhì) |
191732-76-0 |
詳細(xì)
|
BC-1382 |
化合物BC-1382 |
1013753-99-5 |
詳細(xì)
|
MK-1064;MK 1064;MK1064;Urokinase inhibitor 1 |
MK-1064 |
1207253-08-4 |
詳細(xì)
|
SU 4942 |
SU 4942; SU-4942; SU4942 |
76086-99-2 |
詳細(xì)
|
3'-Deoxyguanosine |
3-脫氧鳥苷 |
3608-58-0 |
詳細(xì)
|
BMS-919373;BMS919373;BMS 919373 |
5-(5-phenyl-4-((pyridin-2-ylmethyl)amino)quinazolin-2-yl)pyridine-3-sulfonamide |
1272353-82-8 |
詳細(xì)
|
RSL3;RSL3 1S;1S,3R-RSL3 |
CS-2409 |
1219810-16-8 |
詳細(xì)
|
MS049 |
1502816-23-0 |
1502816-23-0 |
詳細(xì)
|
4i;5-HT3 antagonist-4i;CHEMBL1269981 |
N-(3-CHLORO-2-METHYLPHENYL) QUINOXALIN-2-CARBOXAMIDE |
930478-88-9 |
詳細(xì)
|
Ixazomib citrate;MLN9708 |
枸櫞酸艾沙佐米 |
1239908-20-3 |
詳細(xì)
|
4BP-TQS |
4BP-TQS |
360791-49-7 |
詳細(xì)
|
GSK-2881078;GSK 2881078;GSK2881078 |
GSK-2881078 |
1539314-06-1 |
詳細(xì)
|
NDMC101 |
化合物NDMC101 |
1308631-40-4 |
詳細(xì)
|
TM5007 |
化合物TM5007 |
342595-05-5 |
詳細(xì)
|
VK-II-36 |
化合物VK-II-43 |
955371-66-1 |
詳細(xì)
|
2-hydroxy Flutamide |
羥基氟他胺 |
52806-53-8 |
詳細(xì)
|
WAY-647802 |
1-(4-(6-硝基吡啶-3-基)哌嗪-1-基)乙烷-1-酮 |
852225-20-8 |
詳細(xì)
|
Paucinervin A |
PAUCINERVIN A |
1243249-16-2 |
詳細(xì)
|
Q203;Telacebec;IAP6 |
Q203 |
1334719-95-7 |
詳細(xì)
|
Microfarin;Microcrystalline warfarin;Acid (enol) warfarin |
化合物 T33382 |
101468-14-8 |
詳細(xì)
|